CLINICAL_TRIALS
trial_result
· 2016-06-27
Clinical Trial Update: A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients [Phase 3]
Summary
Phase 3 study assessing the efficacy, safety and tolerability of idebenone in Friedreich's ataxia has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27